08048035968
Leading exporter of Genuine 6-MP 50MG Tablets from India to Singapore - Tampines | Phoenix Exim

1. General Information

6-MP 50 mg Tablets contain mercaptopurine, a purine-antagonist/antimetabolite medicine. It interferes with processes required for the growth and multiplication of certain abnormal cells. Its principal established use is in the treatment of acute lymphoblastic leukemia (ALL), generally as part of a combination chemotherapy regimen.

Mercaptopurine can also be used for certain other conditions in specific clinical circumstances, but such uses should be determined by a specialist based on the patient's diagnosis and treatment plan.

2. Product Information

  • Product: 6-MP 50 mg Tablets
  • Active ingredient: Mercaptopurine
  • Common abbreviation: 6-MP
  • Strength: 50 mg per tablet
  • Dosage form: Oral tablet
  • Drug class: Purine antagonist / antimetabolite
  • Primary therapeutic area: Oncology / hematology
  • Primary established indication: Acute lymphoblastic leukemia (ALL), as part of combination chemotherapy maintenance treatment.

The exact manufacturer, pack size, formulation and regulatory status can vary by market and product presentation.

3. Uses of 6-MP 50 mg Tablets

6-MP is primarily used:

  • As part of maintenance chemotherapy for acute lymphoblastic leukemia (ALL).
  • In combination with other chemotherapy medicines according to an oncology treatment protocol.
  • In certain circumstances, specialists may prescribe mercaptopurine for other conditions, but these uses depend on clinical judgment and local treatment guidelines.

4. Benefits of This Medicine

When appropriately prescribed, mercaptopurine may:

  • Help control the growth of abnormal leukemia cells.
  • Support the maintenance phase of ALL treatment.
  • Form an important component of combination chemotherapy protocols.
  • Help reduce the risk of leukemia cells continuing to proliferate during maintenance treatment.

The expected benefit depends on the patient's leukemia subtype, treatment protocol, other medicines being used and individual response.

5. Side Effects of This Medicine

Mercaptopurine can cause significant adverse effects because it affects rapidly dividing cells and blood-cell production.

Potential side effects include:

  • Bone-marrow suppression
  • Anemia
  • Reduced white blood cell count
  • Reduced platelet count
  • Nausea and vomiting
  • Diarrhea
  • Loss of appetite
  • Rash
  • Hair loss
  • Liver toxicity
  • Increased susceptibility to infections
  • Unusual bruising or bleeding

Serious complications can occur, including severe myelosuppression and hepatotoxicity, so regular medical monitoring is essential.

6. Common Side Effects

Reported adverse reactions include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Reduced appetite
  • Rash
  • Malaise or tiredness
  • Anemia
  • Leukopenia
  • Thrombocytopenia

The FDA prescribing information identifies myelosuppression, including anemia, leukopenia and thrombocytopenia, as the most common adverse reaction.

Seek urgent medical attention for symptoms such as fever or signs of infection, unusual bleeding or bruising, severe weakness, breathing difficulty, or yellowing of the skin or eyes.

7. How to Use 6-MP 50 mg Tablets

6-MP should be taken exactly according to the oncologist's prescription.

  • Take it by mouth as directed.
  • Take it at approximately the same time each day if prescribed once daily.
  • Do not change the dose or treatment schedule yourself.
  • Do not stop treatment without speaking with your healthcare professional.
  • If a dose is missed, follow the instructions provided by your doctor or pharmacist rather than taking an extra dose.

The FDA labeling gives a commonly recommended starting range of 1.5–2.5 mg/kg once daily for ALL maintenance therapy, but the actual dose must be individualized according to blood counts, treatment protocol, organ function and other factors. A 50 mg tablet strength does not mean that every patient should take 50 mg daily.

8. How This Medicine Works

Mercaptopurine is a purine antagonist and antimetabolite. After entering the body's metabolic pathways, it interferes with the formation and use of purine-related compounds needed for DNA and RNA synthesis.

By interfering with these processes, mercaptopurine inhibits the growth and multiplication of susceptible rapidly dividing cells, including leukemia cells.

9. Safety Advice for This Medicine

Regular blood tests: Blood counts need to be monitored because mercaptopurine can significantly suppress bone marrow function.

Liver monitoring: Liver enzymes and bilirubin may need monitoring because mercaptopurine can cause hepatotoxicity.

Genetic factors: TPMT and NUDT15 genetic differences can increase the risk of severe toxicity in some patients. Testing may be considered according to the treatment setting and clinical judgment.

Infections: Because treatment can suppress immune function, promptly report fever, sore throat, chills or other signs of infection.

Drug interactions: Tell your doctor about all medicines and supplements you take. Important interactions include allopurinol and warfarin, among others.

Pregnancy: Mercaptopurine may cause fetal harm. Discuss pregnancy and contraception with your healthcare professional before and during treatment.

Vaccinations: Do not receive vaccinations, particularly live vaccines, without discussing them with your treating healthcare professional.

10. FAQs

Q1. What is 6-MP 50 mg?
6-MP 50 mg is a tablet containing 50 mg of mercaptopurine, a prescription antimetabolite used principally in ALL treatment.

Q2. What does 6-MP stand for?
6-MP stands for 6-mercaptopurine, the active ingredient mercaptopurine.

Q3. What is 6-MP mainly used for?
It is mainly used as part of combination chemotherapy for maintenance treatment of acute lymphoblastic leukemia (ALL).

Q4. Can I take 6-MP without a prescription?
No. It is a potent prescription chemotherapy medicine and should be taken only under qualified medical supervision.

Q5. Does everyone take one 50 mg tablet daily?
No. The dose is individualized. Treatment protocols may calculate the dose according to body weight and adjust it according to blood counts, toxicity and other clinical factors.

Q6. What monitoring is required?
Doctors commonly monitor blood counts and liver function during treatment, with additional monitoring based on the patient's condition.

Q7. What should I do if I develop a fever?
Contact your healthcare professional promptly because mercaptopurine can reduce blood-cell counts and increase infection risk.

Q8. Can 6-MP interact with other medicines?
Yes. Important interactions include allopurinol and warfarin, and other medicines may also require consideration. Always provide your doctor with a complete medication list.

Q9. Can I stop 6-MP when I feel better?
Do not stop it without your oncologist's advice. Maintenance chemotherapy is generally planned for a specific duration and treatment protocol.

Q10. Is 6-MP the same as mercaptopurine?
Yes. 6-MP is a common abbreviation for 6-mercaptopurine/mercaptopurine.

11. Substitute for 6-MP 50 mg Tablets

There is no universal substitute for 6-MP because the appropriate alternative depends on the disease, chemotherapy protocol, treatment response and patient-specific factors.

Thioguanine (6-thioguanine) is another thiopurine medicine, but it is not automatically interchangeable with mercaptopurine and should not be substituted without a specialist's instruction. Other leukemia medicines may also be used in different treatment protocols, but they are not direct substitutes.

A doctor or oncology pharmacist should determine the appropriate alternative based on the patient's treatment plan.

12. Keywords

Primary keywords:

  • 6-MP 50 mg Tablets
  • 6-MP 50 mg
  • Mercaptopurine 50 mg Tablets
  • 6-Mercaptopurine 50 mg
  • Mercaptopurine Tablets
  • 6-MP Tablets
  • 6-MP medicine
  • Mercaptopurine medicine
  • 6-MP leukemia medicine
  • Mercaptopurine for ALL
  • Acute lymphoblastic leukemia medicine
  • ALL maintenance chemotherapy
  • Antimetabolite medicine
  • Purine antagonist
  • Oncology medicines
  • Hematology medicines
  • Prescription chemotherapy tablets

B2B / Export-focused keywords:

  • 6-MP 50 mg Tablets exporter from India
  • Mercaptopurine 50 mg exporter India
  • 6-MP 50 mg pharmaceutical exporter
  • 6-Mercaptopurine tablets supplier India
  • 6-MP 50 mg medicine supplier
  • Mercaptopurine tablets wholesale supplier
  • 6-MP 50 mg tablets international supplier
  • 6-MP medicine exporter from Nagpur
  • Pharmaceutical exporter Nagpur India
  • Mercaptopurine 50 mg tablets for international supply
  • 6-MP 50 mg tablets export supplier
  • Oncology medicine exporter India
  • Cancer medicine supplier India
  • 6-MP 50 mg tablets USA supply
  • 6-MP 50 mg tablets UK supply
  • 6-MP 50 mg tablets Australia supply
  • 6-MP 50 mg tablets Canada supply
  • 6-MP 50 mg tablets Singapore supply
  • 6-MP 50 mg tablets South Korea supply
  • 6-MP 50 mg tablets UAE supply
Aug 19th, 2026 3:05 PM

Keywords